Lisa O'Neill|February 5, 2024A high-performance neuroprosthesis for speech decoding and avatar control
Lisa O'Neill|February 5, 2024Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial